Compound 212
Identifiers
- Canonical SMILES:
C[C@@H](Oc1cccc2[nH]nc(C)c12)C(=O)N1CCN(C[C@H]1C)C(=O)c1ccccc1
- IUPAC name:
(2S)-1-[(2R)-4-benzoyl-2-methylpiperazin-1-yl]-2-[(3-methyl-2H-indazol-4-yl)oxy]propan-1-one
- InChi:
InChI=1S/C23H26N4O3/c1-15-14-26(23(29)18-8-5-4-6-9-18)12-13-27(15)22(28)17(3)30-20-11-7-10-19-21(20)16(2)24-25-19/h4-11,15,17H,12-14H2,1-3H3,(H,24,25)/t15-,17-/m1/s1
- InChiKey:
JHVGTAQPCZXVSX-NVXWUHKLSA-N
External links
168318250 |
24635188 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
0 | 1 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD4 / gp120 | 7.80 | HIV infectious disease | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 406.20 g/mol | |||
HBA | 7 | |||
HBD | 1 | |||
HBA + HBD | 8 | |||
AlogP | 2.30 | |||
TPSA | 78.53 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 0 | 1 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5746 | Facinicline | DB05586 | |
0.5474 | Tiropramide | DB13091 | |
0.5298 | Fipexide | DB13790 | |
0.5175 | Cinchocaine | DB00527 | |
0.5114 | N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE | DB07279 | |
0.5000 | Flecainide | DB01195 | |
0.4966 | Alizapride | DB01425 | |
0.4957 | Bavisant | DB12299 | |
0.4898 | Granisetron | DB00889 | |
0.4892 | N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide | DB07307 | |
0.4880 | OTX-008 | DB13123 | |
0.4870 | 1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE | DB06869 | |
0.4851 | Roxatidine acetate | DB08806 | |
0.4848 | Troxipide | DB13419 | |
0.4836 | Itopride | DB04924 |